Chilton Capital Management LLC Has $487,000 Stock Holdings in Lam Research Corporation $LRCX

Chilton Capital Management LLC lessened its position in shares of Lam Research Corporation (NASDAQ:LRCX) by 11.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,000 shares of the semiconductor company’s stock after selling 670 shares during the quarter. Chilton Capital Management LLC’s holdings in Lam Research were worth $487,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in LRCX. Brighton Jones LLC lifted its stake in shares of Lam Research by 1,032.4% during the fourth quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock valued at $1,025,000 after acquiring an additional 12,936 shares during the period. GAMMA Investing LLC lifted its stake in Lam Research by 21.5% in the first quarter. GAMMA Investing LLC now owns 29,408 shares of the semiconductor company’s stock valued at $2,138,000 after buying an additional 5,213 shares during the period. Spire Wealth Management lifted its stake in Lam Research by 29.0% in the first quarter. Spire Wealth Management now owns 6,716 shares of the semiconductor company’s stock valued at $488,000 after buying an additional 1,511 shares during the period. Transcend Capital Advisors LLC lifted its stake in Lam Research by 2.3% in the first quarter. Transcend Capital Advisors LLC now owns 8,065 shares of the semiconductor company’s stock valued at $586,000 after buying an additional 182 shares during the period. Finally, Golden State Wealth Management LLC lifted its stake in Lam Research by 18.5% in the first quarter. Golden State Wealth Management LLC now owns 2,249 shares of the semiconductor company’s stock valued at $164,000 after buying an additional 351 shares during the period. Institutional investors and hedge funds own 84.61% of the company’s stock.

Lam Research Stock Up 2.8%

NASDAQ:LRCX opened at $151.68 on Monday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21. The company has a market cap of $191.27 billion, a PE ratio of 33.41, a PEG ratio of 1.66 and a beta of 1.84. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $153.70. The stock has a 50-day simple moving average of $123.23 and a 200 day simple moving average of $100.07.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.22 by $0.04. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.Lam Research’s quarterly revenue was up 27.7% on a year-over-year basis. During the same period last year, the company earned $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, sell-side analysts expect that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, September 24th were issued a dividend of $0.26 per share. The ex-dividend date was Wednesday, September 24th. This is a boost from Lam Research’s previous quarterly dividend of $0.23. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.7%. Lam Research’s dividend payout ratio is 22.91%.

Analyst Ratings Changes

LRCX has been the topic of several analyst reports. Wells Fargo & Company increased their target price on Lam Research from $135.00 to $145.00 and gave the company an “equal weight” rating in a research note on Thursday. The Goldman Sachs Group raised their price target on Lam Research from $115.00 to $160.00 and gave the stock a “buy” rating in a research report on Wednesday, October 8th. Raymond James Financial raised their price target on Lam Research from $90.00 to $110.00 and gave the stock an “outperform” rating in a research report on Thursday, July 31st. Needham & Company LLC raised their price target on Lam Research from $150.00 to $160.00 and gave the stock a “buy” rating in a research report on Thursday. Finally, Cowen reaffirmed a “buy” rating on shares of Lam Research in a research report on Thursday. One research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $147.57.

Insider Activity

In related news, SVP Vahid Vahedi sold 52,190 shares of the stock in a transaction dated Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the transaction, the senior vice president directly owned 251,047 shares in the company, valued at approximately $34,870,428.30. This trade represents a 17.21% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.31% of the company’s stock.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.